Business Standard

FDC gains 7% ahead of board meet for share buyback

The stock was up 7% to Rs 256 on BSE ahead of board meeting today to consider share buyback proposal and unaudited financial results for the quarter ended December 2017.

pharma
Premium

According to UNAIDS, India has 2.1 million people living with HIV

SI Reporter Mumbai
FDC was up 7% to Rs 256 on BSE ahead of board meeting today to consider share buyback proposal and unaudited financial results for the quarter ended December 2017.

“The board of directors shall meet on February 8, 2017 to consider the proposal for buyback of fully paid up equity shares of the Company through tender offer route, up to such amount of the aggregate of Company's paid up equity share capital and free reserves as the Board may decide,” FDC on February 3, 2018 said in a BSE filing.

Earlier, on January 09, 2018, the pharmaceutical company

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in